Existing investor McKesson Ventures co-led the $22.5m round, which will enable IVX Health to open additional infusion and injection therapies centres.
US-based infusion centre operator IVX Health received $22.5m on Monday in a funding round co-led by McKesson Ventures, the investment arm of medical product distributor McKesson.
Venture capital firm Health Velocity Capital co-led the round, which also featured fellow VC firms Nueterra Capital and CrimsoNox Capital.
IVX Health operates centres that provide infusion and injection therapies for patients suffering with chronic conditions such as rheumatoid arthritis, Crohn’s disease and multiple sclerosis.
The company’s centres are open on evenings and weekends…
